Carere R G, Webb J G, Miyagishima R, Djurdev O, Ahmed T, Dodek A
Division of Cardiology, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.
Cathet Cardiovasc Diagn. 1998 Feb;43(2):124-9. doi: 10.1002/(sici)1097-0304(199802)43:2<124::aid-ccd2>3.0.co;2-c.
A retrospective study was conducted to determine the frequency and nature of groin complications when the Vasoseal (Datascope Corp., NJ) hemostasis device was used on 204 occasions to enable removal of the groin sheath in anticoagulated patients. The patients had undergone balloon angioplasty (53%), coronary stenting (20%), and diagnostic angiography (27%). Complications included vascular surgery in 5% including 2 embolized collagen plugs, failure to achieve hemostasis (2%), late external bleeding (2%), purulent discharge (1.5%), a minor ooze of blood (7%), hematomas >6 cm (6%), and hematomas < or = 6 cm (7%). One or more complications occurred with 64 of 204 (30.5%) uses. Multivariate analysis identified diagnostic angiography to be associated with a reduced risk of complications [odds ratio (OR) 0.25], while stent procedure (OR 2.7) and female gender (OR 2.5) were associated with increased risk. This complication rate is similar to other reported series except for a higher rate of vascular surgery. The high incidence of anticoagulation in our study patients (94%) may explain this difference. We recommend caution and adherence to the recommended technique when the device is used in anticoagulated patients.
我们进行了一项回顾性研究,以确定在204例接受抗凝治疗的患者中使用Vasoseal(Datascope公司,新泽西州)止血装置以移除腹股沟鞘管时腹股沟并发症的发生频率及性质。这些患者接受了球囊血管成形术(53%)、冠状动脉支架置入术(20%)和诊断性血管造影(27%)。并发症包括5%的患者需要进行血管手术,其中2例为胶原栓塞,2%的患者止血失败,2%的患者出现迟发性外出血,1.5%的患者有脓性分泌物,7%的患者有轻微渗血,6%的患者血肿直径>6 cm,7%的患者血肿直径≤6 cm。204次使用中有64次(30.5%)出现了一种或多种并发症。多因素分析显示,诊断性血管造影与并发症风险降低相关[比值比(OR)0.25],而支架置入术(OR 2.7)和女性(OR 2.5)与并发症风险增加相关。除血管手术发生率较高外,该并发症发生率与其他报道的系列相似。我们研究中的患者抗凝比例较高(94%),这可能解释了这种差异。我们建议在抗凝患者中使用该装置时要谨慎并遵循推荐技术。